what to use with igf 1 lr3 Recombinant human IGF-1 protein (Qk041) IGF-1 LR3 1mg Vial |

doi: 10.1016/j.toxlet.2009.11.023

497 Tubeimoside-I, a heat shock protein inhibitor, has been reported to synergize with Oxaliplatin in CRC by increasing ROS levels, downregulating HSPD1, and upregulating ER stress and MAPK pathways, thereby enhancing the anticancer effects of Oxaliplatin

Glutathione is the main active ingredient

The hormesis concept: strengths and shortcomings

Retrieved 7 April 2015

CrossRef Dihydrotanshinone I exhibits antitumor effects via -catenin downregulation in papillary thyroid cancer cell lines Elisabetta Molteni, Federica Baldan, Giuseppe Damante, Lorenzo Allegri Scientific Reports.2024;[Epub] CrossRef Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib Pu Chen, Jianling Wang, Yao Yao, Yiping Qu, Meiju Ji, Peng Hou Endocrine.2024